Developer docs
API playgroundTry for free, no card

Search company profiles

Loyal Valley Capital

Full company profile

uuid0000o6t

Namestring
Loyal Valley Capital
Legal namestring
正心谷资本
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Loyal Valley Capital (正心谷资本) is a thematic, research-driven private equity and venture capital firm founded in 2015 and headquartered in Shanghai, China. The firm invests across technology, healthcare, consumer, and industrial sectors in China, with a disclosed portfolio spanning internet platforms (ByteDance, Bilibili), consumer brands (Pop Mart), biopharmaceuticals (Junshi Biosciences, Henlius, Nuconvance, Vivacta Biotechnology), medical robotics (Beijing Surgerii Robotics), optoelectronic communications (Angna Technology), industrial automation (Zhengkong Technology), and electronic measurement (Puyuan Precision Electronics). Its operating model centers on equity capital deployment into early and growth-stage companies, complemented by strategic support and, in select cases, board representation at portfolio companies.

The firm's go-to-market is institutional deal-making: leading or co-leading financing rounds and syndicating with strategic and financial co-investors such as OrbiMed, Eisai Innovation Inc., Decheng Capital, Shanghai Healthcare Capital, and Hefei Industrial Investment. Recent lead investments — over US$50 million across Vivacta Biotechnology's Series A and Series A+ and a US$100 million Series D for Beijing Surgerii Robotics — demonstrate a concentration on healthcare and medtech, with funds earmarked for clinical development and international commercialization respectively. Loyal Valley Capital does not appear to publish product-level pricing; as a PE firm its revenue mechanics derive from management fees and carried interest on committed capital, neither of which is publicly disclosed.

The firm is led by founding partner Andy Lin alongside managing directors Jason Zhao and Jay Gu and executive director Yang Yi. Portfolio leadership is concentrated among high-profile Chinese entrepreneurs and scientists, including ByteDance founder Zhang Yiming, Bilibili chairman Chen Rui, Pop Mart founder Wang Ning, and Nuconvance co-founder Dr. Shi Yigong, indicating a relationship-driven investment platform anchored to elite domestic founder networks.

Short descriptiontext

Loyal Valley Capital (正心谷资本) is a Shanghai-based thematic private equity firm investing across Chinese technology, healthcare, consumer, and industrial sectors, with a portfolio spanning ByteDance, Bilibili, Pop Mart, and leading biotech and medtech companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersShanghai, China
HQ citystring
Shanghai
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
venture capital, private equity, growth investing, thematic investing, portfolio investment
Industry2 codes
1Geography-Focused Venture Capital (Regional/Emerging Markets)
CodeFSANAAAEPrimaryYes
2Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryNo
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • Other Financial Investment Activities5239
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Private Equity
No data
Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Loyal Valley Capital (正心谷资本) is a thematic, research-driven private equity and venture capital firm that invests in growth-stage Chinese companies across sectors including biotechnology, medical devices, semiconductors, internet platforms, entertainment, consumer products, and industrial automation. The firm leads and co-leads financing rounds, provides strategic support, and places representatives on portfolio company boards, with a portfolio that includes ByteDance, Bilibili, Pop Mart, Junshi Biosciences, Henlius, Nuconvance, Angna Technology, Zhengkong Technology, and Puyuan Precision Electronics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Loyal Valley Capital (正心谷资本) is a venture capital firm that provides investment services to early and growth-stage companies. The firm focuses on portfolio companies including Angna Technology (optical communications), Bilibili (entertainment), ByteDance (internet technology), Pop Mart (consumer products), Junshi Biosciences (biopharmaceuticals), Hengrui Hanlin (biologics), Nuocheng Jianhua (biopharmaceuticals), Zhongkong Technology (industrial automation), and Puyuan Jingdian (electronic measurement). The investment portfolio spans high-tech industries including communications, entertainment, internet platforms, consumer products, biotech, and industrial technology.

Product and service1 record
1Loyal Valley Capital Investment Services
CategoryVenture Capital / Private Equity
Description

Venture capital and private equity investment services providing funding and strategic support, including board representation, to growth-stage companies in China across biotechnology, medical devices, internet platforms, entertainment, consumer products, semiconductors, and industrial automation sectors.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Hillhouse is one of China's largest and most established multi-sector investment platforms, investing across consumer, healthcare, technology, and business services — directly comparable to Loyal Valley's broad sector coverage and Chinese geographic focus.

TypeDirect peer
Description

HongShan is a leading China-focused venture and growth investor backing technology, healthcare, and consumer companies — a direct competitor for early-to-growth stage deals across Loyal Valley's core verticals.

TypeBroad incumbent
Description

Boyu is a major Greater China-focused alternative investment firm spanning PE growth, venture, and real assets. Directly comparable as a multi-sector China investment platform with similar scale and stage.

TypeDirect peer
Description

IDG Capital is one of the pioneering China-focused VC firms with broad sector coverage in technology, healthcare, and consumer — competing for similar early-to-growth stage deals across Loyal Valley's verticals.

TypeDirect peer
Description

Primavera Capital is a China-focused growth and buyout investor with significant healthcare and tech exposure — closely comparable in stage, geography, and sector mix to Loyal Valley Capital.

TypeDirect peer
Description

Source Code Capital is a China-focused VC firm investing across internet platforms, enterprise tech, and consumer — comparable as a Chinese growth-stage investor with similar sector breadth and ticket size.

TypeDirect peer
Description

Qiming is a leading China-focused VC firm with strong healthcare and tech franchises. Directly comparable as a sector-broad Chinese venture investor competing in many of the same deals.

TypeBroad incumbent
Description

CDH is one of China's largest alternative asset managers spanning PE, VC, and credit. Comparable as a multi-stage, multi-sector China investment platform with significant healthcare exposure.

TypeDirect peer
Description

Matrix Partners China is a long-standing China-focused early-stage venture firm investing in tech, healthcare, and consumer — comparable in stage, geography, and sector focus to Loyal Valley Capital.

TypeDirect peer
Description

5Y Capital is a China-focused growth equity investor with deep internet, enterprise tech, and consumer portfolios — comparable as a multi-sector Chinese growth-stage investor of similar vintage.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment104 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Loyal Valley Capital

Venture Capital / Private Equityloyalvalleycapital.com

Loyal Valley Capital (正心谷资本) is a Shanghai-based thematic private equity firm investing across Chinese technology, healthcare, consumer, and industrial sectors, with a portfolio spanning ByteDance, Bilibili, Pop Mart, and leading biotech and medtech companies.

What Loyal Valley Capital does

Loyal Valley Capital (正心谷资本) is a thematic, research-driven private equity and venture capital firm founded in 2015 and headquartered in Shanghai, China. The firm invests across technology, healthcare, consumer, and industrial sectors in China, with a disclosed portfolio spanning internet platforms (ByteDance, Bilibili), consumer brands (Pop Mart), biopharmaceuticals (Junshi Biosciences, Henlius, Nuconvance, Vivacta Biotechnology), medical robotics (Beijing Surgerii Robotics), optoelectronic communications (Angna Technology), industrial automation (Zhengkong Technology), and electronic measurement (Puyuan Precision Electronics). Its operating model centers on equity capital deployment into early and growth-stage companies, complemented by strategic support and, in select cases, board representation at portfolio companies.

The firm's go-to-market is institutional deal-making: leading or co-leading financing rounds and syndicating with strategic and financial co-investors such as OrbiMed, Eisai Innovation Inc., Decheng Capital, Shanghai Healthcare Capital, and Hefei Industrial Investment. Recent lead investments — over US$50 million across Vivacta Biotechnology's Series A and Series A+ and a US$100 million Series D for Beijing Surgerii Robotics — demonstrate a concentration on healthcare and medtech, with funds earmarked for clinical development and international commercialization respectively. Loyal Valley Capital does not appear to publish product-level pricing; as a PE firm its revenue mechanics derive from management fees and carried interest on committed capital, neither of which is publicly disclosed.

The firm is led by founding partner Andy Lin alongside managing directors Jason Zhao and Jay Gu and executive director Yang Yi. Portfolio leadership is concentrated among high-profile Chinese entrepreneurs and scientists, including ByteDance founder Zhang Yiming, Bilibili chairman Chen Rui, Pop Mart founder Wang Ning, and Nuconvance co-founder Dr. Shi Yigong, indicating a relationship-driven investment platform anchored to elite domestic founder networks.

Loyal Valley Capital firmographics

Firmographics
Name
Loyal Valley Capital
Legal name
正心谷资本
Website
https://www.loyalvalleycapital.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
Loyal Valley Capital (正心谷资本) is a Shanghai-based thematic private equity firm investing across Chinese technology, healthcare, consumer, and industrial sectors, with a portfolio spanning ByteDance, Bilibili, Pop Mart, and leading biotech and medtech companies.
Ownership category
akta.pro rank

Loyal Valley Capital industry classification

Industry
Product category
Venture Capital / Private Equity
NAICS
Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Investment Advice (6282)
akta.pro primary industry
Geography-Focused Venture Capital (Regional/Emerging Markets) (FSANAAAE)
akta.pro secondary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

  • Venture capital
  • Private equity
  • Growth investing
  • Thematic investing
  • Portfolio investment

Where Loyal Valley Capital is headquartered

Location

Headquarters

HQ city
Shanghai
HQ country
China
HQ region
Asia

Markets served

Loyal Valley Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Loyal Valley Capital product offering

Product offering

Core offering

Loyal Valley Capital (正心谷资本) is a thematic, research-driven private equity and venture capital firm that invests in growth-stage Chinese companies across sectors including biotechnology, medical devices, semiconductors, internet platforms, entertainment, consumer products, and industrial automation. The firm leads and co-leads financing rounds, provides strategic support, and places representatives on portfolio company boards, with a portfolio that includes ByteDance, Bilibili, Pop Mart, Junshi Biosciences, Henlius, Nuconvance, Angna Technology, Zhengkong Technology, and Puyuan Precision Electronics.

Product overview

Loyal Valley Capital (正心谷资本) is a venture capital firm that provides investment services to early and growth-stage companies. The firm focuses on portfolio companies including Angna Technology (optical communications), Bilibili (entertainment), ByteDance (internet technology), Pop Mart (consumer products), Junshi Biosciences (biopharmaceuticals), Hengrui Hanlin (biologics), Nuocheng Jianhua (biopharmaceuticals), Zhongkong Technology (industrial automation), and Puyuan Jingdian (electronic measurement). The investment portfolio spans high-tech industries including communications, entertainment, internet platforms, consumer products, biotech, and industrial technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Loyal Valley Capital Investment Services Venture capital and private equity investment services providing funding and strategic support, including board representation, to growth-stage companies in China across biotechnology, medical devices, internet platforms, entertainment, consumer products, semiconductors, and industrial automation sectors.

Companies that use Loyal Valley Capital

Customer profile

Ideal customer profiles3 records

Loyal Valley Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Loyal Valley Capital partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Loyal Valley Capital competitors and assessment

Company assessment

Broad incumbents

  • Hillhouse Capital: Hillhouse is one of China's largest and most established multi-sector investment platforms, investing across consumer, healthcare, technology, and business services — directly comparable to Loyal Valley's broad sector coverage and Chinese geographic focus.
  • Boyu Capital: Boyu is a major Greater China-focused alternative investment firm spanning PE growth, venture, and real assets. Directly comparable as a multi-sector China investment platform with similar scale and stage.
  • CDH Investments: CDH is one of China's largest alternative asset managers spanning PE, VC, and credit. Comparable as a multi-stage, multi-sector China investment platform with significant healthcare exposure.

Direct peers

  • Sequoia Capital China (HongShan): HongShan is a leading China-focused venture and growth investor backing technology, healthcare, and consumer companies — a direct competitor for early-to-growth stage deals across Loyal Valley's core verticals.
  • IDG Capital: IDG Capital is one of the pioneering China-focused VC firms with broad sector coverage in technology, healthcare, and consumer — competing for similar early-to-growth stage deals across Loyal Valley's verticals.
  • Primavera Capital: Primavera Capital is a China-focused growth and buyout investor with significant healthcare and tech exposure — closely comparable in stage, geography, and sector mix to Loyal Valley Capital.
  • Source Code Capital: Source Code Capital is a China-focused VC firm investing across internet platforms, enterprise tech, and consumer — comparable as a Chinese growth-stage investor with similar sector breadth and ticket size.
  • Qiming Venture Partners: Qiming is a leading China-focused VC firm with strong healthcare and tech franchises. Directly comparable as a sector-broad Chinese venture investor competing in many of the same deals.
  • Matrix Partners China: Matrix Partners China is a long-standing China-focused early-stage venture firm investing in tech, healthcare, and consumer — comparable in stage, geography, and sector focus to Loyal Valley Capital.
  • 5Y Capital: 5Y Capital is a China-focused growth equity investor with deep internet, enterprise tech, and consumer portfolios — comparable as a multi-sector Chinese growth-stage investor of similar vintage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Loyal Valley Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Loyal Valley Capital leadership team

Management profile

Number of profiles

Profiles4 records

Loyal Valley Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Loyal Valley Capital M&A and investment

M&A and investment

M&A

Investments104 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Loyal Valley Capital

What does Loyal Valley Capital do?

Loyal Valley Capital (正心谷资本) is a thematic, research-driven private equity and venture capital firm that invests in growth-stage Chinese companies across sectors including biotechnology, medical devices, semiconductors, internet platforms, entertainment, consumer products, and industrial automation. The firm leads and co-leads financing rounds, provides strategic support, and places representatives on portfolio company boards, with a portfolio that includes ByteDance, Bilibili, Pop Mart, Junshi Biosciences, Henlius, Nuconvance, Angna Technology, Zhengkong Technology, and Puyuan Precision Electronics.

Is Loyal Valley Capital a public or private company?

Loyal Valley Capital is a private company. It is classified as unknown and is currently operating.

When was Loyal Valley Capital founded?

Loyal Valley Capital was founded in 2015. It employs 51 to 100 people.

Where is Loyal Valley Capital based?

Loyal Valley Capital is headquartered in Shanghai, China, in the Asia region.

Who are Loyal Valley Capital's main competitors?

Broad incumbents on record are Hillhouse Capital, Boyu Capital and CDH Investments. Direct peers are Sequoia Capital China (HongShan), IDG Capital, Primavera Capital, Source Code Capital, Qiming Venture Partners, Matrix Partners China and 5Y Capital.

Does Loyal Valley Capital have an API?

No public API is recorded for Loyal Valley Capital.

What industry is Loyal Valley Capital in?

Loyal Valley Capital's product category is Venture Capital / Private Equity. Its primary akta.pro industry code is FSANAAAE, Geography-Focused Venture Capital (Regional/Emerging Markets), with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DoNews消息称高瓴创投合伙人严文韬有望加入 DeepSeek,担任首席财务官- DoNewsDeepSeek's CFO position is expected to be filled by Yan Wentao, a Hillhouse Capital partner, who is leaving his role. The company raised about 51 billion yuan in external financing in June, with Liang Wenfeng among investors. Yan, born in 1991, has projects including ByteDance and MiniMax.PedailyHuaxia Yingtai has completed over 200 million yuan in Series C financing, led by Zhengxin Valley Capital.Huaxia Yingtai completed over 200 million RMB in Series C financing led by Zhengxin Valley Capital, with Fudan Science and Technology participating. The funds will advance clinical development of YTS109 and build the In vivo STAR-T platform. The company plans to accelerate cell therapy applications in tumors and autoimmune diseases.ChinaventureHuaxia Yingtai completed over 200 million yuan in Series C financingHuaxia Yingtai completed over 200 million RMB in Series C financing on July 6, 2026, led by Zhengxin Valley Capital with Fudan Science and Technology participating. The funds will advance clinical development of its universal STAR-T core product YTS109 and build a commercialization system and global IP layout.JixinBlue Star Guangyu, a provider of all-scenario laser communication solutions, has received hundreds of millions in Series C financing.Blue Star Guangyu received hundreds of millions in C+ round financing, led by Yongxin Ark, following a May 2025 C round of nearly 500 million. The company is using funds for core material reserves and strategic cooperation, and provided 7 products for a May 2026 satellite launch, marking a new stage of on-orbit delivery.Fastdata极数上海mRNA药物和基因编辑药物研发商尧唐生物获得5亿人民币C轮融资 – Fastdata极数YaoTang Bio, a Shanghai mRNA and gene editing drug developer, raised 500 million RMB in Series C financing led by Zhenxin Valley Capital. The company focuses on in vivo gene editing drugs for genetic and cardiovascular diseases, with participation from multiple investors.pharmaphorumWindward raises $165m for TSLP drug, and other biofinancingsWindward Bio raised $165 million in crossover financing to extend its cash runway for clinical trials of its TSLP inhibitor WIN378. The drug, licensed from Kelun-Biotech, is in phase 2/3 for asthma, with phase 2 dosing data expected later this year. The round brings total funding above $365 million.MedpathVivacta Bio Secures Over $50 Million in Series A Funding to Advance In Vivo CAR-T Therapy GT801Vivacta Biotechnology completed Series A and A+ financing rounds totaling over $50 million, led by Loyal Valley Capital and Decheng Capital. The funds will advance clinical trials and regulatory submissions for its in vivo CAR-T therapy GT801, which showed promising safety and efficacy in early studies. The company plans to use the capital for global expansion and research team expansion.Vietnam Investment ReviewVivacta Bio closes over $50 mln in Series A, A+ financingVivacta Biotechnology closed over $50 million in Series A and A+ financing led by Loyal Valley Capital and Decheng Capital. The funds will advance clinical trials for its GT801 in vivo CAR-T therapy and support regulatory submission. Initial human data for GT801 was reported at ASH 2025.AllsciVivacta Biotech Closes $50M Series A FundingShanghai-based Vivacta Biotechnology closed combined Series A and Series A+ financing exceeding USD 50 million to fund its in vivo CAR-T platform, with lead candidate GT801 in active Phase I trials. Loyal Valley Capital led the Series A, Decheng Capital the Series A+, with OrbiMed, Hankang Capital, Eisai Innovation, C&D Emerging Industry Equity and existing shareholders participating. Proceeds will support clinical trials, regulatory submission and global expansion.TechStartupsFintech startup Squads raises $18M to build a stablecoin-powered financial OSSquads raised $18M in a strategic round led by Solana Ventures, bringing total funding to $42.9M. The capital will accelerate Altitude, its stablecoin-based financial OS, which has processed over $200M in payments since its December 2025 launch. The platform aims to replace legacy banking infrastructure for global businesses.